CHD Bioscience partners with Dr. Reddy’s Labs for global licensing of DFA-02

CHD Bioscience partners with Dr. Reddy’s Labs for global licensing of DFA-02

FORT COLLINS -- India-based Dr. Reddys Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and Fort Collins-based CHD Bioscience Inc. , a privately-held biopharmaceutical company, today... Read More

Thursday July 27, 2017 0 comments Tags: Fort Collins, CHD Bioscience, Dr. Reddy's Laboratories, Michael Handley, DFA-02